What is the recommended neoadjuvant chemotherapy regimen for osteosarcoma?

The MAP regimen (Methotrexate, Adriamycin, Cisplatin) is the standard neoadjuvant chemotherapy for osteosarcoma, aimed at tumor shrinkage and improving surgical outcomes.